Retraction

A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer

Paper Information

Record ID:
4299
Author(s):
Zhiyu Li
John Fallon
John Mandeli
James Wetmur
Savio L C Woo
Journal:
Journal of the National Cancer Institute ( Oxford University Press )
Publication Date:
October 01, 2008
Retraction Date:
February 24, 2010 (15.7 years years ago)
Subjects:
Broad Categories:
Microbiology Medicine Biology Genetics
Institution:
Department of Gene and Cell Medicine, Department of Pathology, Department of Community and Preventative Medicine, Department of Microbiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1496, New York, NY 10029-6574, USA
Country:
🇺🇸 United States
Article Type:
Research Article
Publisher:
Oxford University Press
Open Access:
Yes
DOI:
10.1093/jnci/djn308
PubMed ID:
18812551
Retraction PubMed ID:
20176752

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.1093/jnci/djq027
Additional Notes:

Misconduct findings for Zhiyu Li: https://ori.hhs.gov/content/case-summary-li-zhiyu

Citations (18)

18
Total Citations
11
Post-Retraction
(61.1%)
5
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
5 Within 1 year
6 After 2+ years
3800 Days since retraction (latest)
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Jul 2020
3800 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Dec 2019
3568 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Apr 2016
2228 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Oct 2015
2072 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: May 2015
1892 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Aug 2013
1275 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Jan 2011
323 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Nov 2010
250 days after retraction
Paper citing The oncopathic potency of Clostridium perfringens ...
Unknown Authors
Unknown Journal
Published: Jul 2010
142 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Jul 2010
127 days after retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Jul 2010
127 days after retraction
Paper citing The oncopathic potency of Clostridium perfringens ...
Unknown Authors
Unknown Journal
Published: Feb 2010
2 days before retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Feb 2010
23 days before retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Feb 2010
23 days before retraction
Hypoxic Tumors and Their Effect on Immune Cells and Cancer Therapy
Patricia Yotnda, Danli Wu, Anna May Swanson
Methods in molecular biology
Published: Jan 2010
50 citations
54 days before retraction
Paper citing A genetically enhanced anaerobic bacterium for onc...
Unknown Authors
Unknown Journal
Published: Jul 2009
238 days before retraction
Quick Stats
Total Citations: 18
Years Since Retraction: 15.7 years
Open Access: Yes
Last Checked: Never
Related Papers
Increasing power in screening trials by testing control-arm…
Journal of the National Cancer Institute • 4 citations
Randomized Trial of First-Line Tyrosine Kinase Inhibitor Wi…
Journal of the National Cancer Institute • 193 citations
Clinical Characteristics and Outcomes of COVID-19–Infected …
Journal of the National Cancer Institute • 196 citations
Clinical Characteristics and Outcomes of COVID-19-Infected …
Journal of the National Cancer Institute • 0 citations
Relationship Between Increased Fucosylation and Metastatic …
Journal of the National Cancer Institute • 17 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice